Tech company named for Vista

First interested tenant will seek tax breaks, bring 44 jobs

Bethlehem's Vista Technology Campus.

Bethlehem's Vista Technology Campus. Photo by Marcy Velte.

— Bethlehem's Vista Technology Campus may soon have its first technology tenant.

The town's Industrial Development Agency is in discussions with Breonics Inc., an Albany company specializing in organ regeneration research that is interested in leasing space within a new building proposed for a now undeveloped portion of the campus. Breonics is considering the move because the lease at their current location in the state’s Harriman Research Center is ending.

“I think that’s really good news for the town because this is what Vista Tech Campus was designed to do: house tech companies while providing jobs and tax revenue to the area,” said IDA Chairman Frank Venezia.


The Vista Technology Campus plot behind Shoprite where Breonics is expected to make its home.

Breonics would occupy part of a 27,000-square-foot building on a plot behind the Shoprite grocery store. The company would occupy about 6,000 square feet of the building and is expected to bring 44 new jobs to the area, mostly lab technicians. Representatives have also told the town the company they may expand within the next couple of years.

Breonics Chairman Ernie Green said the company’s current home is owned by the state’s Office of General Services. Because of statewide consolidation efforts, all of the tenants within the Harriman Research Center will have until August to relocate, he said. Officials expect construction at Vista to begin soon after the project is approved because of the timeline.

“We’re looking for a place we can retrofit going forward, so we thought an entirely new building would be better,” Green said. “We have to reconstruct a new work area and clean room and this way we’ll have something more suited to our needs.”

The biomedical research and development company now has 10 employees but plans to expand with the move. They are waiting on several grants and some possible financing and will soon go forward with a new clinical trial involving the regeneration of kidney tissue for transplant patients.

Vote on this Story by clicking on the Icon


Use the comment form below to begin a discussion about this content.

Sign in to comment